T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Motorola Solutions
MSI
$76.5B
| $204M | 0.02% |
941,236
-14,539
| -2% | -$2.9M |
|
|
KRTX
552
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $203M | 0.02% |
1,783,268
+92,493
| +5% | +$10.8M |
|
553
Xencor
XNCR
$1.69B
| $202M | 0.02% |
5,863,909
+164,248
| +3% | +$6.51M |
|
|
ONC
554
BeOne Medicines Ltd
ONC
$40.4B
| $200M | 0.02% |
582,093
-147,837
| -20% | -$49M |
|
|
ATVI
555
DELISTED
Activision Blizzard
ATVI
| $200M | 0.02% |
2,091,977
+68,721
| +3% | +$6.51M |
|
556
Minerals Technologies
MTX
$2.27B
| $199M | 0.02% |
2,528,626
-161,934
| -6% | -$13.1M |
|
557
BJ's Restaurants
BJRI
$1.44B
| $199M | 0.02% |
4,045,070
-12,675
| -0.3% | -$701K |
|
|
NBIS
558
Nebius Group N.V.
NBIS
$70.1B
| $199M | 0.02% |
2,805,682
+455,604
| +19% | +$29.9M |
|
|
GBIO
559
DELISTED
Generation Bio
GBIO
| $198M | 0.02% |
736,312
+87,858
| +14% | +$26.3M |
|
560
Middleby
MIDD
$5.29B
| $197M | 0.02% |
1,138,285
-231,699
| -17% | -$39.5M |
|
|
AIRC
561
DELISTED
Apartment Income REIT Corp.
AIRC
| $197M | 0.02% |
4,150,845
-545,083
| -12% | -$25.1M |
|
562
Cavco Industries
CVCO
$4.62B
| $196M | 0.02% |
884,306
-32,553
| -4% | -$7.09M |
|
563
Liberty Energy
LBRT
$3.5B
| $196M | 0.02% |
13,866,886
-366,312
| -3% | -$4.94M |
|
564
Guardant Health
GH
$21.6B
| $196M | 0.02% |
1,579,295
+38,411
| +2% | +$5.17M |
|
565
AES
AES
$10.5B
| $196M | 0.02% |
7,510,910
-1,089,658
| -13% | -$28.8M |
|
566
Zai Lab
ZLAB
$2.9B
| $195M | 0.02% |
1,103,967
+42,319
| +4% | +$6.81M |
|
567
Replimune Group
REPL
$1.44B
| $195M | 0.02% |
5,069,450
+1,991,208
| +65% | +$68.1M |
|
568
Target
TGT
$70.2B
| $195M | 0.02% |
805,341
-13,701
| -2% | -$3M |
|
569
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.67B
| $194M | 0.02% |
2,009,441
+595,525
| +42% | +$52M |
|
570
Wingstop
WING
$3.06B
| $194M | 0.02% |
1,230,083
+1,215,178
| +8,153% | +$175M |
|
571
Albemarle
ALB
$15.5B
| $193M | 0.02% |
1,144,574
+147,895
| +15% | +$23.9M |
|
572
WIX.com
WIX
$3.05B
| $193M | 0.02% |
664,221
-2,874,163
| -81% | -$806M |
|
573
Evergy
EVRG
$19.3B
| $193M | 0.02% |
3,186,755
-1,472,243
| -32% | -$92.1M |
|
574
CRISPR Therapeutics
CRSP
$5.19B
| $193M | 0.02% |
1,189,273
-109,056
| -8% | -$13.3M |
|
575
Simon Property Group
SPG
$71.9B
| $192M | 0.02% |
1,474,693
-58
| -0% | -$7.21K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.